StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Credit Suisse Downgrades ZS Pharma (ZSPH) to Neutral on Takeover
November 9, 2015 6:24 AM
Credit Suisse downgraded ZS Pharma (NASDAQ: ZSPH) from Outperform to Neutral with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
JPMorgan Downgrades ZS Pharma (ZSPH) to Neutral
November 9, 2015 7:17 AM
Morgan Stanley Downgrades ZS Pharma (ZSPH) to Equalweight
November 9, 2015 7:16 AM
AstraZeneca (AZN) to Acquire ZS Pharma (ZSPH) in $2.7B Deal
November 6, 2015 6:36 AM
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion
November 6, 2015 2:19 AM
